BusulfanTransplantation ConditioningMyeloablative AgonistsBone Marrow TransplantationAntineoplastic Agents, AlkylatingCyclophosphamideHepatic Veno-Occlusive DiseaseTransplantation, HomologousVidarabineWhole-Body IrradiationGraft vs Host DiseaseAlkylating AgentsImmunosuppressive AgentsTransplantation, AutologousMelphalanTreatment OutcomeThiotepaGraft SurvivalDrug MonitoringAdministration, OralDrug EvaluationHematologic NeoplasmsCombined Modality TherapyDose-Response Relationship, DrugLeukemiaAntineoplastic Combined Chemotherapy ProtocolsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSulfonic AcidsSpermatogoniaMyelodysplastic SyndromesHistocompatibilityTransplantation ChimeraOogoniaAntilymphocyte SerumPharmaceutical SolutionsLeukemia, Myeloid, AcuteLeukemia, MyeloidSurvival AnalysisTime FactorsInjections, IntravenousSeminiferous Tubules